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Lithocholic acid (LCA) deposited in human livers always induces drastic pains which
need analgesic drug, like morphine to release. Our research showed that LCA
can effectively inhibit uridine 5’-diphospho-glucuronosyltransferase 2B7 (UGT2B7) in
morphine tolerance-like human normal liver cells, HL-7702, then increase µ-opioid
receptor (MOR) and calcium–calmodulin dependent protein kinase IIα (CaMKIIα)
expression. In vivo assay, UGT2B7 was significantly repressed in the livers of acute
or chronic morphine tolerance mice pretreated with LCA (10, 50, and 100 mg/kg,
p.o.). To investigate the connections between LCA function performance and change
of UGT2B7 enzymatic activity in mice livers, two morphine metabolites, morphine-3-
glucuronide (M3G) and morphine-6-glucuronide (M6G) were quantified by solid phase
extraction (SPE)–HPLC–MS/MS. The result indicated no matter in acute or chronic
morphine tolerance, the concentrations of M3G and M6G were all decreased, the
later one fell even more. Besides that, 50 mg/kg of LCA administration can prevent
auto-phosphorylation of CaMKIIα at Thr286 in acute or chronic morphine tolerance
mice prefrontal cortexes (mPFCs) due to synthesis increase of cyclic adenosine
monophosphate. As a consequence, UGT2B7 depression mediated by LCA can affect
its selective catalysis ability to morphine, that may be responsible to acute or chronic
morphine tolerance alleviation. These findings might assist to modify antinociception of
morphine in clinic.
Keywords: lithocholic acid, UGT2B7, CaMKIIα, cAMP, morphine tolerance
INTRODUCTION
Bile acids deposited in livers of patients mainly occurs in primary biliary cirrhosis (PBC), and
accompanies with many complications, such as hepatic failure (Vlahcevic et al., 1981; Ishibashi
et al., 2011; Jankowska and Socha, 2012). As one of vital secondary bile acids derived from primary
chenodeoxycholic (CDCA) (de Paiva et al., 2015), lithocholic acid (LCA) is regarded as a main
index to diagnose hepatic diseases (Lucangioli et al., 2009) which can be increased significantly in
PBC induced extrahepatic cholestasis (Ceryak et al., 1998). When LCA accumulates in liver, the
drastic pains (like abdominal pain) occur immediately (Laurin et al., 1994). The intensity of pains
Frontiers in Pharmacology | www.frontiersin.org 1 November 2016 | Volume 7 | Article 404
fphar-07-00404 October 27, 2016 Time: 16:45 # 2
Yang et al. LCA Mediated Morphine Tolerance Reverse
are caused by acute or chronic maladies velocity of bile acid
(Saraswat et al., 2004; Traub et al., 2008). To better control and
release the pain, some opioid analgesic drugs were preferably
used in clinic practice. However, accompanying with their
applications, tolerance would come into being.
Some serious changes of biomolecules in signal pathways
will be acted out subsequently in tolerance. For example,
µ-opioid receptor (MOR) will be internalized with sensitivity
loss (Werling et al., 1989; Ravindranathan et al., 2009) and
auto-phosphorylated with itself expression decline (Deng et al.,
2001). Besides, under such condition, calcium flow excreted
from the cell membranes will restrain the voltage-dependent
Ca2+ channels (VDCCs) to remit (Yokoyama et al., 2004). As
one of key calcium ions secretory proteins, Ca2+/calmodulin-
dependent protein kinase IIα (CaMKIIα) which is correlated with
opioids tolerance in central nervous system will be suppressed
in direction alteration of calcium ion flow (Chen et al., 2010;
Hu et al., 2015). Some studies demonstrated that the tolerance
induced Ca2+ influx can also stimulate N-methyl-D-aspartate
(NMDA) receptors and cause CaMKIIα auto-phosphorylation at
position Thr286 (Fukunaga et al., 1992; Strack et al., 2000), which
means Thr286 may be responsible to the reverse of tolerance.
Analgesic opioid drug, morphine as a UGT2B7 substrate, can
be converted to morphine-3-glucuronide (M3G) and morphine-
6-glucuronide (M6G) in the human livers (Stone et al., 2003;
De Gregori et al., 2012). They are playing different roles in
morphine antinociceptive tolerance. Compared to morphine and
M3G, M6G is more potent opioid agonist which has higher
affinity to µ and κ receptors (Frances et al., 1992). It also
holds stronger tolerance than morphine when they were treated
to mice in the same dose (Faura et al., 1996). In contrast,
M3G which owns a weaker µ receptors activation ability was
considered to antagonize the analgesia activity of morphine and
M6G (Christrup, 1997; Faura et al., 1997). Therefore, morphine
induced tolerance would be released by M3G.
To selectively change glucuronidation of morphine, a
hypothesis of regulating the enzymatic activity of UGT2B7 was
proposed. It was reported that Src (one of non-receptor tyrosine
kinase proteins) dependent phosphorylation of UGT2B7 can
selectively metabolize catechol-estrogens and 17β-estradiol in
COS-1 cells (Mitra et al., 2009, 2011). That may exemplify
the hypothesis. More importantly, UGT2B7 downregulation was
explored after LCA accumulation in human colon cells, Caco-2
(Lu et al., 2005). It indicated that as an endogenous compound,
LCA may potentially repress UGT2B7 in livers and impact its
enzymatic activity to metabolize morphine. In order to verify
these, we performed several assays in vitro and in vivo.
MATERIALS AND METHODS
Experimental Materials
Penicillin, streptomycin, fetal bovine serum (FBS), trypsin,
Dulbecco’s modified Eagle medium (DMEM) were acquired
from GIBCO (Invitrogen Life Technologies, USA). RIPA
Lysis Buffer, PMSF were bought from Beyotime (Beyotime
Biotechnology, Nantong, China). Goat serum (Santa Cruz, Los
Angeles, CA, USA). RNA simple Total RNA Kit (Tiangen,
China). Hematoxylin (Sigma, Sigma-Aldrich, Shanghai, China).
siRNAs and all the primers for qPCR were designed and
synthesized by Sangon Company (Sangon Biotech, Shanghai,
China). PrimeScript RT reagent Kit (Perfect Real Time) and
SYBR Premix Ex Taq (Tli RNaseH Plus) were purchased from
Takara Company (Takara, Japan). Bull Serum Albumin (BSA),
RIPA, PMSF were obtained from Beyotime Company (Beyotime
Biotech, Shanghai, China). Rabbit polyclonal antibody against
µ-opioid receptor (MOR) (ab10275), CaMKII (ab22609), Thr286
phosphorylation of CaMKII (ab32678) and UGT2B7 (ab126269)
were purchased from the Abcam Company (Shanghai, China).
Mouse monoclonal antibody against glyceraldehyde phosphate
dehydrogenase (GAPDH) was purchased from KangChen Bio-
tech Inc. (Shanghai, China). HRP-conjugated goat anti-rabbit
or anti-mouse IgG(G+L) was obtained from MultiSciences
Biotech Co, Ltd. (Hangzhou, China). ECL Western Blotting
Substrate (Biomiga, San Diego, CA, USA). Lipofectamine 3000
and 2-Solution DAB Kit was purchased from Invitrogen Life
Technologies Company (San Jose, CA, USA). Mouse cAMP
Parameter Assay ELISA Kit was purchased from R&D systems
(Minneapolis, MN, USA).
Lithocholic acid was purchased from the Sigma-Aldrich
Company (St. Louis, MO, USA). Morphine, M3G, and M6G were
purchased from Cerilliant Corporation (Round Rock, TX, USA).
M6G-d3, as internal standard, was labeled by Biomag System
Company (Changshu, Jiangsu, China). HPLC-grade methanol
and formic acid were purchased from Tedia Company (Fairfield,
OH, USA). Ultrapure water (18.2 M) was obtained from an
ELGA–pure lab Ultra system (High Wycombe, UK).
Waters HLB C18 solid phase extraction (SPE) columns were
obtained from Waters Company (Waters, Milford, MA, USA).
Agilent HILC PLUS SB-C18 column (2.1 mm × 50 mm,
3.5 µm, Agilent, USA). Data acquisition and processing were
performed using Analyst 1.5.2 (AB SCIEX). All centrifugations
were performed on an Eppendorf 5415R Refrigerated Micro-
centrifuge (Eppendorf, Germany).
Cell Cultivation
Normal human liver cells, HL-7702 were cultured at an
atmosphere of 5% CO2 and 95% air at 37◦C. DMEM, being as its
cultivation medium supplemented with 10% FBS, 1% penicillin,
streptomycin. The cells were passaged by 0.25% EDTA mixed
with trypsin. All the compounds diluted with DMSO were added
into DMEM medium and incubated for a serious of hours. Then
we changed old medium to fresh one containing with different
concentrations of each compound every 24 h. Same volumes of
DMSO (less than 0.1%) were treated the cells as control.
Animals
ICR mice (male, body weight of 20–25 g) were obtained
from Experimental Animals Department of Zhejiang University.
Animals were fed in a breeding room with temperature at 25◦C,
humidity of 50 ± 10%, and a 12 h dark–light cycle. They
were free to approach water and rodent chows all the time.
All the experimental animals were cultivated under the above
conditions for 7 days to acclimate, then they were weighted and
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recorded every day before the drugs treatment. The animals were
administrated with different compounds twice a day based on
the mice weights. Animal experiments were strictly conducted in
accordance with the protocols approved by the Ethics Committee
for Animal Studies at Zhejiang University. The paperwork was
according to the documentation of ‘The Detailed Rules and
Regulations of Medical Animal Experiments Administration and
Implementation’ (Document No. 1998–55, Ministry of Public
Health, China).
siRNA Transfection
HL-7702 cells were seeded in 6-well plates at a density of
0.5 × 105/well. The pairs of sequences for siRNA-621
which can specific knocked down homo UGT2B7 were
CCUACGUACCUGUUGUUAUTT as positive sense, and
AUAACAACAGGUACGUAGGTT as antisense, respectively.
The negative control (NC) siRNA was with sequences of
UUCUUCGAACGUGUCACGUTT as positive sense and
ACGUGACACGUUCGGAGAATT as antisense, respectively. In
brief, 200 nM siRNA was treated in non-serum DMEM medium
combining with the reagent of Lipofectamine 3000 and incubated
5 min at room temperature, after that all the mixture solutions
were added to the cells. After 5.5 h incubation, the medium was
mixed with serum including all the compounds and cultivated
for another 48 h (transfer the medium again at 24 h). Then all
the cells were harvested to make a further detection.
Quantitative Real-Time PCR
HL-7702 cells were seeded in 6-well plates at a density of
0.5× 105/well. After administrated with different concentrations
of compounds, the cells were cultivated for 48 h (changed the
medium including drugs at 24 h). Then total RNAs were isolated
from cells, and cDNA was synthesized. Real-time PCR was
carried out on a StepOne plus Real-Time PCR system, samples
were mixed by SYBR. Expression of each target mRNA was
normalized to housekeeping gene glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The primer pairs for related genes
were based on the Table 1.
Tests of Acute and Chronic Morphine
Tolerance and Antinociception in Mice
ICR mice were pretreated with LCA (p.o.) for 7 days at
different concentrations (10 mg/kg, 50 mg/kg, and 100 mg/kg)
in 0.9% saline solutions. Then the acute or chronic morphine
tolerance mice models were established and validated based on
the method previously reported (Hu et al., 2015). During this
period, each group of mice was treated with different doses of
LCA and same volumes of 0.9% saline solutions as a control.
Tail-flick assay was performed to estimate basal nociception
and morphine-induced antinociception as described previously
(Tang et al., 2006; Yang et al., 2011). The latency of quick tail-
flick response was recorded and expressed as the percentage
of maximal possible effect (MPE%) based on the following
formula:
%MPE = 100 × (postdruglatency − predruglatency)
(cutoff − predruglatency)
A cutoff time of 12 s was used to prevent from the potential
injure of mice tissues.
Immunohistochemistry
The livers of mice were resected and harvested, then fixed in
4% paraformaldehyde for 12 h and kept in cold 30% sucrose-
PBS solution overnight. The sections were exposed to 0.3%
H2O2 (final concentration in PBS) to reduce the endogenous
peroxidase for 30 min. Then, the reaction was blocked with
10% goat serum in PBS, and the reaction mixture incubated
with primary rabbit polyclonal antibodies UGT2B7 (diluted with
1:500) overnight at 4◦C and HRP-conjugated goat anti-rabbit
polyclonal secondary antibody (1:2000) for 1 h. All sections
were treated with a peroxidase substrate solution. Hematoxylin
and 3,3′-diaminobenzidine tetra hydrochloride (DAB) were used
as counterstaining reagents. The prepared slides were observed
with×200 of magnification under Olympus BX41 microscope to
measure the UGT2B7 expression. The NC group without primary
antibody was carried out with the same procedure as described
above.
Western Blotting Assay
The total proteins were extracted from the cell lysates or mouse
brain prefrontal cortexes (mPFCs) after they were incubated with
RIPA lysis buffer containing 1x PMSF. The protein concentration
of each sample was determined by BCA kit. Then, 50 µg protein
samples were subjected to SDS-PAGE and transferred on PVDF
membranes. The membranes were incubated in blocking solution
containing 5% BSA in TBST buffer (100 mM Tris-HCl, pH7.4,
150 mM NaCl and 0.1% Tween 20) for 1 h at room temperature
before overnight incubated with primary antibody at 4◦C. The
primary antibodies were diluted by TBST buffer including
TABLE 1 | The information of primer sequences used in qPCR assay.
Names ID Sense (5′–3′) Antisense (5′–3′)
hUGT2B7 NM_001074.2 AAGAAAGGGCCAACGTAATT AGAGCCGAGTATTGAGACCTAA (108 bp)
hMOR NM_000914.4 ACAGGCAAGGTTCCATAGATTG CTGGCATAATGAAGGCGAAGAT (105 bp)
hCaMKIIα NM_015981.3 ATCCCCACATCCACCTGAT GGGTGATGACATGGGAGAAT(304 bp) (Cavazzin et al., 2004)
hGAPDH NM_002046.5 CATGAGAAGTATGACAACAGCCT AGTCCTTCCACGATACCAAAGT (113 bp)
musMOR AH_005396.2 GACTGCTCTGACCCCTTAGCTCC TTGCCATCAACGTGGGACAAG (80 bp)
musCaMKIIα NM_009792.3 AAACAAGAAGAACGATGGTGTGAAG GTGTTGGTGCTCTCAGAAGATTCC (81 bp)
musGAPDH NM_001289726.1 GAGAAACCTGCCAAGTATGATGAC AGAGTGGGAGTTGCTGTTGAAG (129 bp)
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FIGURE 1 | The effect of LCA on UGT2B7 expression in morphine tolerance-like HL-7702 cells. (A) MOR expressed in the cells treated with 1 µM morphine
for 48 h to determine the generation of tolerance. (B) UGT2B7 expressed in the cells co-incubated with 1 µM morphine and various concentrations of LCA (10, 50,
100 µM) for 48 h before same doses of LCA 48 h pretreatment in each group. Results were normalized to GAPDH with mean ± SEM of three independent
experiments. DMSO was used as control in each group. Pairwise comparisons were calculated by student t-test to calculate P-values (∗P < 0.05).
UGT2B7 (1:1000), MOR (1:500), CaMKIIα (1:5000) and Thr286
phosphorylation of CaMKIIα (1:2000). After washing three times
to remove the primary antibody, the HRP-conjugated goat anti-
rabbit IgG (1:2000) as secondary antibody was used for detection
by ECL substrates. Target proteins were visualized by exposing
the membranes to G-box chemiluminescence apparatus carried
Genesnap system for 5 min exposure. GAPDH was paralleled
by using as an internal reference to normalize the expression
of UGT2B7, MOR, CaMKIIα, and Thr286 phosphorylation of
CaMKIIα. Each integrated optical density (IOD) value of stripe
was measured and calculated by Image-Pro Plus 6.0 Software
(Media Cybernetics Corporate, Bethesda, MD, USA).
Preparation of Mice Liver Samples Using
SPE
The integral livers of mice were extracted, then homogenized
by Automatic Tissue Grinder by 15 ml purified water
included with 0.5% formic acid, then centrifuged for 10 min
at 4◦C and 3,000 × g. After that, 2 ml of acetonitrile
was add to 1 ml supernatant to precipitate proteins with
centrifuging at 13,000 × g for 10 min. M6G-d3 (IS) was
applied as internal standard and added to the supernatant
with a final concentration of 10 ng/ml in each sample.
The SPE process based on the method previously reported
(Yang et al., 2016). In brief, the mixture was loaded onto
balanced HLB Waters SPE column to process a secondary
pretreatment activated by 5 ml methanol and eluted by 1 ml
acetonitrile. The eluate, then, was evaporated and dried in a
centrifugal thickener. After dissolved in 100 µl mobile phase and
centrifuged, 10 µl supernatant was injected into HPLC–MS/MS
to determine morphine and its metabolites. The concentrations
of analytes were reflected the quantity in 1ml mice liver
homogenates.
HPLC–MS/MS Methods Validation
All the mice liver homogenate samples were determined by
HPLC–MS/MS. Agilent 1290 infinity LC system equipped
with a G4220A quaternary pump, G4226A auto sampler
and G1330B 1290 thermostat. AB SCIEX 4000 plus triple
quadrupole mass spectrometer (AB SCIEX Technologies) with
an electrospray ionization source were performed for the
HPLC–MS/MS analysis. The auto-sampler was maintained at
4◦C, and the temperature for column compartment was set
at 30◦C. Chromatographic separations were achieved on an
Agilent HILC PLUS SB-C18 column (2.1 mm × 50 mm,
3.5 µm). The mobile phase for analyzing morphine, M3G,
M6G, M6G-d3 (ISTD) consisted of 0.05% formic acid in
purified water (A) and methanol (B) with a gradient elution
of 95% A at 0–1 min, 98% B at 1–3 min, 98% B at
3–6 min, 95% A at 6–7 min with a flowing rate of
0.25 ml/min.
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FIGURE 2 | Alteration Analysis of genes correlated to morphine tolerance after UGT2B7 knocked down in morphine tolerance-like HL-7702 cells. (A)
UGT2B7 mRNA expression or (B) protein expression was determined in the cells which transfected with siRNA (UGT2B7). Tolerance related genes of (C) MOR or
(D) CaMKIIα mRNA expression was determined in siRNA(UGT2B7) transfection cells pretreated with 50 µM LCA for 48 h then co-incubated with 1 µM morphine for
additional 48 h. Results were normalized to GAPDH with mean ± SEM of three independent experiments. DMSO or NC RNA were used as control. Pairwise
comparisons were calculated by student t-test to calculate P-values (∗∗P < 0.01, ∗P < 0.05).
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FIGURE 3 | The effect of LCA on acute or chronic morphine tolerance mice. Tail-flick assays were performed to (A) acute or (B) chronic morphine
administration mice treated with different concentrations of LCA (10, 50, 100 mg/kg; p.o.) based on our previous method for evaluating the changes of morphine
tolerance. Then maximum possible effect (MPE%) were counted based on the formula above. (C) Immunohistochemistry assay was developed to clearly investigate
UGT2B7 expression in mice livers at magnification of 200×. The ratios of IOD values to summary areas were measured and counted to reflect the integral UGT2B7
(labeled with brown color) variations in (D) acute or (E) chronic morphine tolerance mice livers by Image Pro Plus 6.0 software. Results were with mean ± SEM of
three independent experiments. Saline was used as control in each group of mice. Pairwise comparisons were calculated by student t-test to calculate P-values
(∗∗∗∗P < 0.0001, ∗∗P < 0.01, ∗P < 0.05).
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FIGURE 4 | Concentrations of M3G and M6G in different doses of LCA (10, 50, 100 mg/kg; p.o.) treated acute or chronic morphine tolerance mice
livers were determined by (SPE)–HPLC–MS/MS based on the method shown above. Concentration changes of M3G and M6G were measured in (A,C)
acute or (B,D) chronic morphine tolerance mice liver homogenates. 0 mg/kg LCA reflects saline treatment as control in each group of mice. Results were with
mean ± SEM of three independent experiments. Pairwise comparisons were calculated by student t-test to calculate P-values (∗∗∗P < 0.001, ∗∗P < 0.01,
∗P < 0.05).
TABLE 2 | Concentration ratios of M6G to morphine or M6G to M3G in LCA (10, 50, 100 mg/kg, p.o.) treated acute or chronic morphine tolerance mice
livers.
Group Acute morphine tolerance Chronic morphine tolerance
[M6G/Morphine] [M6G/M3G] [M6G/Morphine] [M6G/M3G]
LCA 0 mg/kg 1.30 ± 0.15 1.53 ± 0.08 1.06 ± 0.11 1.02 ± 0.12
LCA 10 mg/kg 1.20 ± 0.26 1.51 ± 0.27 0.79 ± 0.16∗ 1.03 ± 0.22
LCA 50 mg/kg 1.09 ± 0.30∗ 1.43 ± 0.30 0.64 ± 0.19∗∗ 0.91 ± 0.29
LCA 100 mg/kg 0.83 ± 0.28∗∗ 1.10 ± 0.45 ∗ 0.51 ± 0.27∗∗∗ 0.77 ± 0.51∗∗
Drug administration method was shown above. 0 mg/kg LCA reflects saline treatment as control in each group of mice. Results were with mean ± SEM of three
independent experiments. Pairwise comparisons were calculated by student t-test to calculate P-values (∗∗∗P < 0.001, ∗∗P < 0.01, ∗P < 0.05).
Mass spectrometer with ESI source was operated in positive
ionization mode. Parameters of which were set as following:
collision energy, 36 eV for morphine and 43 eV for M3G, M6G,
M6G-d3 (ISTD); Declustering potential, 89 V for morphine, and
85 V for metabolites and M6G-d3(IS). The integral temperature
of drying gas, 350◦C; drying gas flow, 8 L/min; temperature for
ionization 550◦C. Data were acquired using the Analyst 1.5.2
(AB SCIEX) in the multiple reaction monitoring (MRM) mode
by recording ion currents for the following transitions: 286–
200.9 m/z for morphine, 462.1–286.1 m/z for M3G and M6G,
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FIGURE 5 | The level of cAMP synthesis in mPFCs. Concentrations of cAMP determined by ELISA kit in (A) acute or (B) chronic morphine tolerance mice treated
with LCA 50 mg/kg based on the method shown above. Results were with mean ± SEM of three independent experiments. Saline was used as control in each
group of mice. Pairwise comparisons were calculated by student t-test to calculate P-values (∗∗∗∗P < 0.0001).
465.1–289.1 m/z for M6G-d3 (ISTD) in positive mode. The
method has been validated.
ELISA Assay
The ELISA assay was performed to determine the synthesis
concentrations of cyclic adenosine monophosphate (cAMP) in
mPFCs by kit. In brief, cold 0.1 M HCl was added into the
tissue homogenates of mPFCs at a 5:1 ratio, after centrifuged,
the supernatants and standard samples were prepared following
the instructions of the kit. The sample concentrations were
determined at 450 nm on a microplate reader and calculated by
standard curve.
Data Analysis
Statistics data were expressed as mean ± SEM derived from
three paralleled independent experiments. Unpaired two-side
Student’s t-test was applied for comparisons of two groups’ data.
A P-value <0.05 was considered statistically significant. The
immunohistochemistry assay and western blotting assays were
measured by IOD values or the ratios of IOD values to summary
of areas by Image Pro Plus 6.0 software. Western blotting assay
was then normalized to the IOD value of GAPDH in each group.
The figures and statistics were all counted by GraphPad Prism 5.0
(GraphPad Software Inc., San Diego, CA, USA).
RESULTS
LCA Mediated UGT2B7 Down-Regulation
in Morphine Tolerance-Like HL-7702
Cells
Morphine tolerance-like HL-7702 cell model was established
and validated. In brief, 1 µM morphine was added to HL-7702
cells for 48 h, then the total mRNA was extracted from the
cells. The results indicated that MOR decreased significantly
compared to control group, thus the morphine tolerance-like
status was induced in HL-7702 cells (Figure 1A). In order
to investigate the effect of LCA on UGT2B7 expression, HL-
7702 cells were treated with different concentrations of LCA
(10, 50, 100 µM) for 48 h, then the cells were co-incubated
with 1 µM morphine for another 48 h. From the results,
50 µM and 100 µM of LCA can significantly depress UGT2B7
(Figure 1B).
UGT2B7 Knockdown Regulated MOR
and CaMKIIα Expression Increase in
Morphine Tolerance-Like HL-7702 Cells
To further research whether UGT2B7 involved in morphine
tolerance, we transfected siRNA to specifically knock down
UGT2B7 in HL-7702 cells. The data revealed that UGT2B7
was dominantly inhibited in both levels of mRNA and
protein expressions compared to NC siRNA transfection
(Figures 2A,B). Meanwhile, MOR (Figure 2C) and CaMKIIα
(Figure 2D) were all enhanced in HL-7702 cells exposed to
1 µM morphine. However, MOR and CaMKIIα sequentially
increased after the cells were pretreated with 50 µM of LCA
(Figures 2C,D).
Alleviation of Acute or Chronic Morphine
Tolerance via Inhibiting UGT2B7 in Mice
Liver by LCA
To explore the functions of LCA in vivo, morphine was
injected into mice to acquire acute or chronic tolerance status
based on the methods reported previously (Hu et al., 2015).
Significant reverse of morphine tolerance was reflected from
MPE% values after acute or chronic mice accepted LCA
administration. Specifically, 50 mg/kg or 100 mg/kg of LCA
can attenuate morphine antinociceptive tolerance via increasing
their MPE% values by 26.4 or 49.4% for acute tolerance and
24.3 or 42.5% for chronic tolerance. However, 10 mg/kg of LCA
Frontiers in Pharmacology | www.frontiersin.org 8 November 2016 | Volume 7 | Article 404
fphar-07-00404 October 27, 2016 Time: 16:45 # 9
Yang et al. LCA Mediated Morphine Tolerance Reverse
FIGURE 6 | LCA mediated mRNA and protein expression changes of MOR and CaMKIIα in mPFCs after the mice suffered with acute or chronic
morphine induced tolerance. mRNA expression changes of (A,B) MOR or (C,D) CaMKIIα was determined in mPFCs after the mice treated with 50 mg/kg LCA
under (A,C) acute or (B,D) chronic morphine tolerance. Protein expression including MOR, CaMKIIα, and auto-phosphorylation of CaMKIIα at Thr286 was measured
in mPFCs after the mice treated with 50 mg/kg LCA under (E) acute or (F) chronic morphine. IOD value of each protein including MOR, CaMKIIα, and
auto-phosphorylation of CaMKIIα at Thr286 was normalized to GAPDH under (G–I) acute or (J–L) chronic morphine tolerance. Results were with mean ± SEM of
three independent experiments. Pairwise comparisons were calculated by student t-test to calculate P-values (∗∗∗P < 0.001, ∗∗P < 0.01, ∗P < 0.05).
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administration exhibited no significant difference no matter in
acute or chronic morphine tolerance groups (Figures 3A,B).
Besides, immunohistochemistry assay was performed in mice
livers to further detect UGT2B7 expression under 50 mg/kg
of LCA regulation. The ratios of IOD and summary areas
were measured by Image Pro Plus 6.0 software. From the
results, UGT2B7 expression increased in the mice livers under
acute or chronic morphine tolerance. In contrast, UGT2B7
decreased in the mice livers when they were exposed to LCA
(Figures 3C,D,E).
LCA Induced Accumulation Variants of
Two Metabolites in Acute or Chronic
Morphine Tolerance Mice Livers
To illustrate whether LCA can regulate enzymatic activity of
UGT2B7. Morphine, M3G, and M6G were determined in acute
or chronic tolerance morphine mice livers with liver LCA
accumulation. The results indicated that the concentrations of
M3G (Figures 4A,B) and M6G (Figures 4C,D) were all declined.
In addition, both of the ratios of M6G to morphine and M6G to
M3G experienced downtrend. It was important to mention that
no matter in acute or chronic morphine tolerant mice, 100 mg/kg
of LCA resulted in the lowest ratios (Table 2).
Analysis of cAMP Concentration in Acute
or Chronic Morphine Tolerance Mice
Prefrontal Cortexes
cAMP, as one of vital intracellular signaling molecules can be used
to estimate the phosphorylation alterations of total proteins in
targeted animal tissues. To estimate whether LCA contributes to
auto-phosphorylation changes of proteins correlated to tolerance
in mPFCs, the cAMP concentrations were quantified by ELISA
kit. From the data, cAMP in acute or chronic morphine tolerance
mice treated with 50 mg/kg of LCA was changed from 1.80 to
0.76 nM or 1.90 to 0.98 nM, respectively, compared to no LCA
treatment (Figures 5A,B). It indicated, protein phosphorylation
had taken place in these brain sections.
LCA Regulation of Proteins Correlated to
Tolerance in Mice Prefrontal Cortexes
To determine the alterations of some proteins correlated to
tolerance, acute or chronic morphine tolerant mice were treated
with 50 mg/kg of LCA. The results showed that mRNA
and protein of MOR increased predominantly in mPFCs
(Figures 6A,B,E–G,J). We found, compared to MOR, another
vital protein, CaMKIIα had a similar uptrend (Figures 6C–
F,H,K). In contrast, auto-phosphorylation of CaMKIIα at Thr286
was reduced in acute or chronic morphine tolerance mice
treated with 50 mg/kg of LCA (Figures 6E,F,I,J). This result was
in accordance with the concentration alterations of cAMP in
mPFCs.
DISCUSSION
In this study, HL-7702 cells and acute or chronic morphine
tolerance mice models were applied to investigate LCA mediated
alterations of UGT2B7 expression and enzymatic activity. At
the meantime, we also explored the changes of some signals or
proteins correlated to morphine tolerance in the mice brains
under LCA regulation. The brief mechanism has been illustrated
in the diagram of our research (Figure 7).
FIGURE 7 | The mechanism of LCA mediated UGT2B7 down-regulation and acute or chronic morphine tolerance reverse.
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It was reported that MOR can be measured as a vital index
to evaluate the tolerance status (He et al., 2009). Its expression
can be significantly reduced in SH-SY5Y cells treated with 1 µM
morphine for 24 and 48 h (He et al., 2010). To demonstrate
whether LCA can regulate UGT2B7 under tolerance status
in vitro. We established the morphine tolerance-like cells of HL-
7702 and found MOR was significantly repressed in the cells,
which means tolerance-like models had been established.
Yuan et al. once reported that 10 µM of LCA can
downregulate UGT2B7 in Caco-2 cells significantly. In this
research, we found morphine can induce UGT2B7 in HL-
7702 cells though it was not remarkable compared to LCA.
UGT2B7 was also upregulated in mice livers in acute or chronic
morphine-induced tolerance. The above results indicated that
morphine would be a potential weak agonist to UGT2B7.
Similarly, UGT2B7 can be regulated by its substrate zidovudine
though this induction performance may be distinct in different
cell lines. Zidovudine at the concentration from 2 to 100 µM
can activate UGT2B7 in human liver carcinoma cell line
(HepG2), in contrast, it showed a downtrend from 50 to
2500 µM in human thyroid carcinoma cell (THLE2) (Fang et al.,
2014). Therefore, further research should be developed whether
morphine has the similar effects like zidovudine when it regulates
UGT2B7.
To clarify whether LCA intervenes the enzymatic activity
of UGT2B7 by blocking its expression, each concentration
of morphine, M3G or M6G was determined in the livers
of acute or chronic morphine-induced tolerance mice treated
with multiple concentrations of LCA. The results showed that
both concentrations of M3G and M6G were continuously
reduced with the increase of it. Similar trend was observed
in each concentration ratio of M6G to morphine or M6G to
M3G which elucidated that M6G concentration decreased more
rapidly than the other two compounds. That is to say, regio-
selective glucuronidation caused by UGT2B7 downregulation
could change the enzymatic activity and decrease the morphine
tolerance.
In this experiment, we extracted mPFCs to investigate
tolerance dependent signal variations. PFC is a main region
in brains to study opioids-induced tolerance, withdrawal and
addiction (Contet et al., 2008; Liu et al., 2015; Peregud et al.,
2015). From our results, cAMP synthesis decreased significantly
after mice were pretreated with 50 mg/kg of LCA compared
to control groups, which showed the protein targets correlated
to tolerance underwent dephosphorylation. By that means, we
found phosphorylation of CaMKIIα at Thr286 was restricted
in the tolerance induced mPFCs, in contrast, CaMKIIα was
prompted. Since Ca2+ influx mediated the motivation of the
N-methyl-D-aspartate (NMDA) receptor may lead to CaMKIIα
auto-phosphorylation at Thr286 and induce full activation of the
kinase in morphine-induced tolerance (Strack et al., 2000; Zhao
and Joo, 2006). Thus, LCA deposited in the mice livers might
affect morphine brain distribution and attribute to CaMKIIα
dephosphorylation at Thr286 site.
In summary, LCA mediated UGT2B7 down-regulation can
repress the auto-phosphorylation of CaMKIIα and increase
cAMP contents in mPFCs. The expression of UGT2B7 may
change its enzymatic activity by regio-selective altering the
glucuronidation of morphine metabolites in mice livers reflected
from the decrease ratio of M6G to M3G. This mechanism might
be guided to prevent morphine antinociceptive tolerance in
clinic.
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